Discontinued — last reported Q4 '25
Year-over-year, this metric declined by 5.1%, from $53.10M to $50.40M. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows an upward trend with a 22.7% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $91.50M | $8.50M | $0.00 | $0.00 | $57.40M | $15.20M | $0.00 | $0.00 | $45.60M | $0.00 | $0.00 | $100.00M | $0.00 | $53.10M | $200.00M | $0.00 | $0.00 | $50.40M |
| QoQ Change | — | — | — | -90.7% | -100.0% | — | — | -73.5% | -100.0% | — | — | -100.0% | — | — | -100.0% | — | +276.6% | -100.0% | — | — |
| YoY Change | — | — | — | — | — | — | -37.3% | +78.8% | — | — | -20.6% | -100.0% | — | — | -100.0% | — | — | -100.0% | — | -5.1% |